Showing results (11-20 of 137) with videos related to

Sort By:
Pageof 14
Diagnostic Microbiology and Infectious Disease|December 5, 2006
In vitro biofilm characterization and activity of antifungal agents alone and in combination against sessile and planktonic clinical Candida albicans isolatesJennifer A Shuford, Kerryl E Piper, James M Steckelberg, et al.
Journal of Clinical Microbiology|August 6, 2005
Phenotypic and genotypic mupirocin resistance among Staphylococci causing prosthetic joint infectionMargalida Rotger, Andrej Trampuz, Kerryl E Piper, et al.
Mayo Clinic Proceedings|May 12, 2007
Complexity and subtlety of infective endocarditisTimothy E Paterick, Timothy J Paterick, Rick A Nishimura, et al.
Clinical Orthopaedics and Related Research|September 11, 2003
Molecular and antibiofilm approaches to prosthetic joint infectionAndrej Trampuz, Douglas R Osmon, Arlen D Hanssen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 31, 2004
Improved survival in experimental sepsis with an orally administered inhibitor of apoptosisJoel G R Weaver, Mark S Rouse, James M Steckelberg, et al.
Antimicrobial Agents and Chemotherapy|April 9, 2008
In vitro activity of anidulafungin against Candida albicans biofilmsMelissa J Jacobson, Kerryl E Piper, Gary Nguyen, et al.
The Journal of Infection|January 11, 2015
Comparative activities of vancomycin, tigecycline and rifampin in a rat model of methicillin-resistant Staphylococcus aureus osteomyelitisPaschalis Vergidis, Suzannah M Schmidt-Malan, Jayawant N Mandrekar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2007
Infective endocarditis due to penicillin-resistant viridans group streptococciBettina Knoll, Imad M Tleyjeh, James M Steckelberg, et al.
Mayo Clinic Proceedings|July 7, 2012
Infective endocarditis in the pediatric patient: a 60-year single-institution reviewJennifer A Johnson, Thomas G Boyce, Frank Cetta, et al.
Diagnostic Microbiology and Infectious Disease|April 25, 2006
Ceftobiprole medocaril (BAL5788) treatment of experimental Haemophilus influenzae, Enterobacter cloacae, and Klebsiella pneumoniae murine pneumoniaMark S Rouse, Melanie M Hein, Paloma Anguita-Alonso, et al.
Pageof 14